| Literature DB >> 29292759 |
Javier Enrione1, Jonny J Blaker2, Donald I Brown3, Caroline R Weinstein-Oppenheimer4, Marzena Pepczynska5, Yusser Olguín6, Elizabeth Sánchez7, Cristian A Acevedo8,9.
Abstract
In vitro meat has recently emerged as a new concept in food biotechnology. Methods to produce in vitro meat generally involve the growth of muscle cells that are cultured on scaffolds using bioreactors. Suitable scaffold design and manufacture are critical to downstream culture and meat production. Most current scaffolds are based on mammalian-derived biomaterials, the use of which is counter to the desire to obviate mammal slaughter in artificial meat production. Consequently, most of the knowledge is related to the design and control of scaffold properties based on these mammalian-sourced materials. To address this, four different scaffold materials were formulated using non-mammalian sources, namely, salmon gelatin, alginate, and additives including gelling agents and plasticizers. The scaffolds were produced using a freeze-drying process, and the physical, mechanical, and biological properties of the scaffolds were evaluated. The most promising scaffolds were produced from salmon gelatin, alginate, agarose, and glycerol, which exhibited relatively large pore sizes (~200 μm diameter) and biocompatibility, permitting myoblast cell adhesion (~40%) and growth (~24 h duplication time). The biodegradation profiles of the scaffolds were followed, and were observed to be less than 25% after 4 weeks. The scaffolds enabled suitable myogenic response, with high cell proliferation, viability, and adequate cell distribution throughout. This system composed of non-mammalian edible scaffold material and muscle-cells is promising for the production of in vitro meat.Entities:
Keywords: biopolymer; edible material; in vitro meat; scaffold
Year: 2017 PMID: 29292759 PMCID: PMC5744339 DOI: 10.3390/ma10121404
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Experimental strategy.
Formulation of the polymer solutions used for scaffold preparation.
| Formulation 1 | Ao | Ag | Bo | Bg |
|---|---|---|---|---|
| 0.375 | 0.375 | 0.375 | 0.375 | |
| 0.375 | 0.375 | 0.375 | 0.375 | |
| 0.250 | 0.250 | - | - | |
| - | - | 0.250 | 0.250 | |
| - | 0.100 | - | 0.100 |
1 For each formulation name, the letters mean the following: (i) A or B: agar or agarose as gelling excipient, respectively; (ii) g or o: with or without glycerol as plasticizer, respectively.
Figure 2Zeta potential of polymer solutions composed of salmon gelatin and sodium alginate.
Figure 3Microstructure of scaffolds (formulations Ao, Ag, Bo, and Bg). Arrows show the micro-holes.
Properties of the salmon gelatin/alginate scaffolds made with glycerol as plasticizer.
| Properties 1 | Agar as Gelling (Ag) | Agarose as Gelling (Bg) |
|---|---|---|
| 153.2 (±3.6) | 207.8 (±5.4) | |
| 5.8 (±0.5) | 12.8 (±1.0) | |
| 8.6 (±0.5) | 9.4 (±0.1) | |
| 39.4 (±4.6) | 39.5 (±5.8) | |
| 27.4 (±2.1) | 23.9 (±1.8) | |
| 69.2 (±5.5) | 85.1 (±2.9) |
1 Properties values are expressed as mean ± standard deviation.
Figure 4Cell growth of myoblasts seeded onto scaffolds (scaffold thickness ~3 mm).
Figure 5Sorption isotherms of scaffolds.
Figure 6Stiffness of the wet scaffolds.
Figure 7In vitro biodegradation of scaffolds.
Figure 8Behavior of myoblasts inside the scaffold after 48 h of seeding. (A) Photomicrograph of scaffold Ag (histochemical technique); (B) Photomicrograph of scaffold Bg (histochemical technique); (C) Cells seeded on scaffold Bg showing positive immunostaining for BrdU (immuno histochemical technique); (D) Photomicrograph of scaffold Bg (arrowed cell in metaphase).
Figure 9Cell distribution inside the scaffold (formula Bg) after 48 h of seeding. The scaffold thickness is 3 mm (each zone is close to 0.75 mm). The bottom zone is directly in contact with the cell culture plate.